TULSA, Okla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX), a leading contractor to the energy and industrial markets across North America, in connection with the Board’s ...
The American Society of Plastic Surgeons has issued a broad recommendation against gender transition surgeries for youths, becoming the first major medical association in the United States to narrow ...
Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...
On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...
New York City Mayor-elect Zohran Mamdani announced Monday the creation of 17 transition advisory committees made up of more than 400 people to help advise his incoming administration on policy and ...
NYC Mayor-Elect Zohran Mamdani during an event on November 20, 2025 in New York City (photo by BG048/Bauer-Griffin/GC Images) New York City Mayor-elect Zohran Mamdani announced the 28 members of his ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
SEATTLE — Mayor-elect Katie Wilson on Wednesday named a team of local leaders to guide her administration’s transition into office, tapping figures from government, labor, housing and economic ...
Seattle Mayor-elect Katie Wilson named a director and four co-chairs of her transition team Wednesday, marking her first significant decision since her election victory was confirmed last week. The ...
New York City Mayor-elect Zohran Mamdani's transition team has raised over $1 million in less than 10 days. More than 12,700 people have donated to the fund, with an average contribution of about ...
Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.